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Abstract
Introduction Photodynamic therapy (PDT) is a treatment modality involving a dye that is activated by exposure to light 
of a specific wavelength in the presence of oxygen to form oxygen species causing localised damage to microorganisms.
Aim To determine the most effective bactericidal incubation and irradiation times of erythrosine-based PDT on in vivo-
formed dental plaque biofilms.
Methods A randomised controlled study; 18-healthy adult participants wearing intraoral appliances with human enamel slabs 
to collect dental plaque samples in two separate periods of two weeks each for use in arm-1 and arm-2. These accumulated 
dental plaque samples were treated with PDT under different experimental conditions. Incubation times with photosensitiser 
(erythrosine) of 15 min and 2 min were used in arm-1 and arm-2, respectively, followed by light irradiation for either 15 min 
(continuous) or as a fractionated dose (5 × 30 sec). Following treatment, percentage reductions of total bacterial counts 
were compared between the different groups. In addition, confocal laser scanning microscopy (CLSM) and LIVE/DEAD® 
BacLight™ Bacterial Viability Kit were used to visualise the effect of PDT on in vivo-formed biofilms.
Results Significant reductions in the percentage of total bacterial counts (~93–95%) of in vivo-formed biofilms were found 
when using either 2 min or 15min incubation times and applying 15 min continuous light. Although when applying fraction-
ated light, there was more cell death when 15 min incubation time was used (~ 91%) compared with the 2 min incubation 
time (~ 64%). CLSM results supported these findings.
Conclusion Improving the clinical usefulness of PDT by reducing its overall treatment time seems to be promising and 
effective in killing in vivo-formed dental plaque biofilms.
Keywords In vivo biofilm · CLSM · Erythrosine · Incubation time · Irradiation time · Antimicrobial
Introduction
Increases in the incidence of antibiotic/antimicrobial drug-
resistant bacteria necessitates the development of alterna-
tive approaches to the control of dental plaque (Wainwright 
and Crossley 2004; Meisel and Kocher 2005). In addi-
tion, there are limitations associated with the conventional 
approaches to controlling dental plaque, such as parents’ 
lack of awareness/skills of correct brushing technique or 
difficulty manipulating a brush in the mouth (Marshman 
et al. 2016). Moreover, it may be exacerbated in individuals 
with, for example, physical or learning disabilities (Ciancio 
1988; Baker 1993) and younger children (Tahmassebi et al. 
2015). One such alternative treatment is photodynamic ther-
apy (PDT). PDT involves the application of visible light; a 
photosensitiser; and oxygen (Takasaki et al. 2009). The pho-
tosensitiser binds to the target cells and can be activated by 
light of a wavelength that corresponds to one of its absorp-
tion maxima. Following activation, reactive-oxygen species 
are produced that are toxic to microorganisms (Soukos and 
Goodson 2011). PDT possesses several advantages including 
effective targeting of the treatment by appropriate dosimetry 
and application of the photosensitiser and light (Hamblin 
and Hasan 2004; Gursoy et al. 2013). When applied in this 
way, it provides a noninvasive, confined bacterial killing 
 * A. Alsaif 
 aalsaif1986@gmail.com
1 Department of Paediatric Dentistry, University of Leeds, 
Leeds, UK
2 Department Oral Biology, University of Leeds, Leeds, UK
3 Paediatric Dentistry Department, Ministry of Health, 
Kuwait city, Kuwait
792 European Archives of Paediatric Dentistry (2021) 22:791–800
1 3
without harming host tissues and can be carried out in out-
patient settings (Konopka and Goslinski 2007; Gursoy et al. 
2013).
However, in the previous studies, the PDT treatment time 
has been longer than would be ideal for the clinical setting 
(Metcalf et al. 2006; Wood et al. 2006; Tahmassebi et al. 
2015). To our knowledge, there were no reports in the lit-
erature that have compared the efficacy of PDT on in vivo 
formed plaque biofilms with different incubation times with 
erythrosine photosensitiser prior to irradiation. Therefore, 
to further study this and enhance clinical usefulness, this 
work was conducted aiming to reduce the overall treatment 
time for PDT by investigating the bactericidal efficacy after 
different incubation and irradiation times.
Materials and methods
The principal investigator was trained and calibrated in the 
use of aseptic microbiological procedures in microorgan-
isms’ cultures as well as in the preparation of study solutions 
and dilution series and making Columbia Blood Agar (CBA) 
plates, counting bacterial colonies, using microscopy and 
CLSM. Also, the principal investigator was trained in the 
preparation of enamel slabs and making in situ appliances 
prior to commencement of the study and prior the usage of 
these facilities or materials.
Photosensitiser and light source
The photosensitiser, erythrosine-B (Sigma-Aldrich, Ger-
many), was prepared as a filter-sterilised 1mg/ml stock 
solution in Reduced Transport Fluid (RTF) and stored in 
the dark at 4 °C. It was then diluted to the required 220 μM 
concentration, which was found by Tahmassebi et al. (2015) 
to be the most effective bactericidal concentration for PDT 
on in vivo-formed oral biofilms. This was used for all PDT 
treated groups in this study.
A 400 W-Tungsten filament lamp (Aurora, USA), white 
light source, was used to activate erythrosine. It emitted 
22.7 mW/cm2 of light intensity in the wavelength range 
500–550 nm (the region of maximal absorption by eryth-
rosine). Bacterial samples were placed at 30 cm from the 
lamp and the heat-dissipating water bath (Stuart, SBS40, 
UK) was positioned between the samples and the lamp to 
prevent heating.
In situ appliance
Mandibular removable appliances were fabricated according 
to a previously published design (Tahmassebi et al. 2015). 
The appliances consisted of a labial arch wire, acrylic flanges 
buccally on premolars and first permanent molars and a U 
clasp attached to each of the first permanent molars. Three 
sterilised human enamel slabs (3 mm × 2 mm × 2 mm) were 
inserted in the right buccal flange and another three in the 
left buccal flange of each appliance, leaving a 1 mm depth 
for plaque accumulation on the surface of the slab (shown 
in Fig. 1).
The enamel slabs were cut from sound human premo-
lars and permanent molars extracted for orthodontic or 
periodontal reasons at the School of Dentistry using a water 
cooled, Diamond Wire Saw, cutting machine (Well® Wal-
ter EBNER, CH-2400 Le Loche, Germany). These teeth 
were stored in a solution of distilled water and 0.1% thymol 
(Sigma Aldrich, Germany) at room temperature.
Prepared enamel slabs were kept moist in distilled water 
with thymol. Later, they were immersed overnight in sodium 
hypochlorite (12%), followed by thorough rinsing with 
deionised water and immersed overnight in phosphate buff-
ered saline (pH 7.4) and sent to the Department of Immunol-
ogy of the University of Liverpool, where they were exposed 
to gamma radiation (4080Gy). This level of exposure pro-
vides sterilisation without altering the structural integrity 
of the enamel slabs (Amaechi et al. 1999). In addition, the 
use of hypochlorite to treat enamel does not affect biofilm 
development (Watson et al. 2004). Enamel slabs were steri-
lised twice prior to each arm of the study.
Ethical aspects
Ethical approval was obtained from the National Research 
Ethics Service committee of South-Central Berkshire-
B (REC reference number: 14/SC/1226) and the Leeds 
Research and Innovation Committee (DT14/11310 (149271/
WY)). A summary of this study was registered online in a 
publicly accessible database (NHS Health Research Author-
ity) before subject recruitment. This study was conducted 
in full conformance with the laws and regulations of the 
country in which the research was conducted and as per the 
World Medical Association Declaration of Helsinki.
Study design and participants
This was a single centre, randomised study with two 
arms design. Eighteen-healthy participants (16 females, 2 
males), with mean age 34 years (± 10.27), were recruited 
at the Leeds School of Dentistry. The sample size was cal-
culated using the data from the previous pilot study (Tah-
massebi et al. 2015) using a power calculation 80%, which 
resulted in a sample size of at least five per treatment 
group. An explanatory information sheet was provided to 
each participant. Participants had to meet the inclusion 
and exclusion criteria for the study. The inclusion criteria 
were medically fit, normal salivary flow rate (≥ 0.25 ml/
min), DMFT ≥ 1 and to fully understand the procedures 
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and restrictions and willing and likely to comply, as evi-
denced by voluntary written informed consent. Exclusion 
criteria included active oral disease, use of antimicrobial 
therapy and/or antibiotics within 14 and 28 days prior to 
screening or during the study, use of medication affecting 
salivary flow and wearing of prostheses that could affect 
the study procedures. The participants were instructed to 
wear custom-made appliances, at all times for two separate 
periods of two weeks each, except when eating, drinking 
and tooth brushing. At these times, participants placed the 
appliance in damp gauze inside a provided plastic case 
(Henry Schein, USA), to prevent any drying of the accu-
mulated plaque. The enamel slabs were coded and ran-
domly allocated to the in situ appliances using a random 
number generator (http:// statt rek. com/ stati stics/ random- 
number- gener ator).
PDT on in vivo formed plaque biofilms
After 14 days of wearing the appliances, the enamel slabs 
with the accumulated biofilms were removed from the 
appliances and were randomly allocated to the different 
groups using sealed envelopes. The samples were treated 
under four experimental conditions; (a) control 1 (no 
erythrosine, no light) represented by 1-slab; (b) control 
2 (erythrosine, no light) represented by 1-slab; (c) treat-
ment-1 (erythrosine, +15min continuous light) represented 
by 2-slabs (T1A and T1B); (d) treatment-2 (erythrosine, 
+30 sec light pulses for 5-times, separated by dark periods 
of 1min) represented by 2-slabs (T2A and T2B). Duplicate 
slabs were treated in treatment 1 and 2 groups to assess 
the variation of bacterial viability values between the 
Fig. 1  Preparation of in situ 
appliance. a Illustration of tooth 
sectioning. b Right and left lat-
eral views of in situ appliance. c 
Enamel slab in in situ appliance
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duplicates of the same group with a view to validate and 
increase the reliability of the results.
Samples from 15 participants were used for the micro-
biological killing assay to determine the bacterial viabil-
ity values between the different groups. The samples from 
the remaining 3 participants were used for viewing under 
CLSM.
Arm 1 and 2
Figure 2 shows the experimental conditions and the labora-
tory protocol regime which were the same for the two arms 
of the study, except that the incubation time of the plaque 
biofilms with photosensitiser was different. In the 1st arm, 
the incubation time was 15 min, a duration of time that 
was used in the previous study, Tahmassebi et al. (2015), 
whereas, in the 2nd arm, the incubation time was 2 min, a 
duration of time that was found, by our team, to be as effec-
tive as the 15 min incubation time in bacterial killing of 
planktonic cultures of L. casei spp. (un-published data). In 
brief, the six slabs, with accumulated plaque, were removed 
from the appliance and individually transferred to separate 
wells of 12-well tissue culture plates (Costar, Sigma-Aldrich, 
Germany) and completely covered with either 1.5 ml of RTF 
(C1) or 1.5 ml (220 μM) erythrosine (C2, T1A, T1B, T2A 
and T2B). Next, the 12-well plates were covered with foil 
and incubated for 15 min (Arm-1) or 2 min (Arm-2) at room 
temperature. After dark incubation, foil was removed from 
the wells and all plates were placed under the lamp. The 
treatment groups (T1A and T1B) were irradiated continu-
ously for 15 min, while treatment groups (T2A and T2B) 
were irradiated with 30 sec light pulses (×5), separated by 
dark periods of 1 min, using foil to cover these wells during 
the dark periods. Control groups (C1 and C2) were placed 
under the lamp covered with foil (erythrosine, no light); in 
an attempt to treat all groups under same conditions as far 
possible. The bacterial solutions from each well, with the 
enamel slab and the accumulated plaque, were then indi-
vidually transferred to sterile plastic vials (Sterilin, UK), 
and mixed for ~ 30–60 sec, using vortex mixer (Genie-2, 
scientific industries, Inc., USA), with 5–6 sterile glass beads 
of 3 mm diameter each (Sigma-Aldrich, Germany), to dis-
aggregate the plaque biofilms. To determine the number of 
bacteria in a sample, tenfold serial dilutions were prepared 
from the bacterial suspensions of the control and treatment 
groups. 100 μl of each dilution was then plated on Colombia 
blood agar (CBA) (Oxoid, Basingstoke, UK) in triplicate 
(Total = 108 plates for each appliance). The plates were then 
incubated at 37 °C in a 10%  CO2 incubator (Forma Direct 
Heat, Thermo Scientific, USA) for 48 h. After incubation, 
bacterial counts of each plate were quantified using a colony 
counter (Stuart R, SC6, UK) and the colony-forming units 
per millilitre (CFU/ml) was calculated from the mean count 
of each triplicate.
CLSM observations
To visualise the effect of PDT on the in vivo formed bio-
film, samples from 3-participants were treated under dif-
ferent conditions; (a) control (no erythrosine, no light); (b) 
treatment-1 (erythrosine, +15 min continuous light); (c) 
treatment-2 (erythrosine, +30 sec light pulses for 5-times, 
separated by dark periods of 1min). Following treatment, 
samples were stained using the LIVE/DEAD® BacLight™ 
Fig. 2  Laboratory protocol of PDT on in vivo-formed plaque biofilms
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Bacterial Viability Kit (L7012) (Molecular Probes, Eugene, 
OR, USA) as per the manufacturer’s instructions. The bio-
film samples were stained with SYTO9 and Propidium 
iodide for 15 min in the dark. The labelled biofilms were 
viewed using CLSM (Leica TCS SP2, Wetzlar, Germany), 
to investigate, in situ, the viability of bacteria within the 
biofilm. Samples were examined using excitation with an 
argon (488 nm) and HeNe (543 nm) lasers with ×10 and ×63 
water-dipping objective lenses.
Statistical analysis
Microbial counts were expressed as the number of colony-
forming units (CFU) per ml. Each CFU value represented 
the mean count from triplicate samples. Logarithmic trans-
formation  (log10) was applied to the original observations 
(CFU/ml) to make the distribution more symmetric. Percent-
age reduction in bacterial counts in each group was calcu-
lated by dividing the difference in CFU between control and 
treatment groups with the number of CFU from the control 
group from the same subject.
Tests were performed using IBM® SPSS® Statistics Ver-
sion23. A significance level of α < 0.05 was implemented. 
The parametric ANOVA test was used for the normally 
distributed continuous data and the nonparametric Fried-
man test was used for the skewed continuous data, followed 
by a series of Wilcoxon tests to identify where the specific 
difference lay with adjustments for multiple comparisons 
(α = 0.05/number of comparisons). Bland–Altman plot was 
used to evaluate the Intra-examiner reproducibility. Bacte-
rial counts of 10% of the total number of CBA plates used 
in both arms were randomly re-counted 5–7 days following 
the initial counting.
Results
To ensure that the baseline measurement of the accumulated 
plaque in all the six slabs were comparable, we investigated 
the variation of bacterial viability counts among these slabs 
from one participant prior to the main study PDT investiga-
tion. It revealed no variation in the CFU/ml among these six 
in vivo formed biofilm samples over the 14 days of plaque 
accumulation (Coefficient of variation = 0.01). This was in 
agreement with the previous studies carried out by our team 
(un-published data) and Arweiler et al. (2004).
Arm‑1: 15 min incubation time
The percentage reduction in viable counts following each 
irradiation protocol is shown in Table 1a and Figure 3a. 
The results showed a statistically significant difference in 
the percentage reduction of bacterial counts between the 
two control groups (p = 0.001) and also between these 
control groups with the four treatment groups in all sub-
jects, p = 0.001 (< 0.003). All four treatment groups had a 
Table 1  Percentage (%) reduction in viable counts and mean log10 
CFU/ml obtained from the in vivo formed biofilms treated under 
different experimental conditions when using an incubation time of 
15 min (a) or 2 min (b): C1 (No erythrosine, no light); C2 (Erythros-
ine, no light); T1A and T1B (Erythrosine, +15 min continuous light); 
T2A and T2B (Erythrosine, +30  sec light pulses for 5 times, sepa-
rated by dark periods of 1 min)
(a) Arm-1: 15 min incubation time
Treatment conditions N Mean % (SD) Min. % Max. % Median % Mean log10 
CFU/ml (SD)
(C1): E−L− 13 0.00 (±0.00) 0.00 0.00 0.00 6.08 (±0.79)
(C2): E+L− 13 42.14 (±18.76) 17.08 74.66 32.46 5.82 (±0.76)
(T1A): E+(15 min)L+ 13 89.13 (±13.35) 64.03 99.82 94.27 4.72 (±0.80)
(T1B): E+(15 min)L+ 13 87.45 (±16.33) 55.40 99.68 95.73 4.75 (±0.81)
(T2A): E+(5 × 30 s)L+ 13 83.15 (±17.50) 46.39 99.47 88.15 5.06 (±0.86)
(T2B): E+(5 × 30 s)L+ 13 85.10 (±16.92) 47.48 99.71 91.37 4.95 (±0.90)
(b) Arm-2: 2 min incubation time
Treatment conditions N Mean % (SD) Min. % Max. % Median % Mean log10 
CFU/ml (SD)
(C1): E−L− 15 0.00 (±0.00) 0.00 0.00 0.00 5.76 (±0.72)
(C2): E+L− 15 20.21 (±13.99) 3.31 46.13 19.26 5.66 (±0.70)
(T1A): E+(15 min)L+ 15 85.05 (±17.25) 52.31 99.30 93.22 4.52 (±0.72)
(T1B): E+(15 min)L+ 15 85.75 (±14.92) 56.52 99.35 89.92 4.62 (±0.65)
(T2A): E+(5 × 30s)L+ 15 63.50 (±27.10) 25.41 98.89 62.34 5.13 (±0.64)
(T2B): E+(5 × 30s)L+ 15 68.77 (±26.32) 18.86 99.20 64.09 4.95 (±0.83)
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significantly higher percentage reduction in their bacterial 
counts than the control groups. However, there was no sta-
tistically significant difference between the four treatment 
groups (p > 0.003).
Arm‑2: 2 min incubation time
The percentage reduction in viable counts following each 
irradiation protocol is shown in Table 1b and Figure 3b. 
The results showed a statistically significant difference in 
the percentage reduction of bacterial counts between the 
two control groups (p = 0.001) and also between these con-
trol groups with the four treatment groups in all subjects, 
p = 0.001 (< 0.003). All four treatment groups had a signifi-
cantly higher percentage reduction in their bacterial counts 
than the control groups. In addition, there was a statistically 
significant difference between the treatment groups irradi-
ated with 15min continuous light (T1A and T1B) and the 
groups with the fractionated light (p < 0.003) with a higher 
percentage reduction of bacterial counts (up to ≈ 93%) seen 
in the 15 min continuous light groups (T1A and T1B).
In terms of intra-examiner reliability, one sample t test 
showed a nonstatistically significant difference between the 
counts performed in two different time periods (p = 0.220, 
> 0.05). Furthermore, a Bland–Altman plot showed a high 
level of agreement between the two measurements (most of 
the values were close to the zero line and within the 95% 
confidence interval limits).
CLSM observations
Figure 4 shows CLSM images of PDT-treated and control 
biofilms. The majority of the cells showed green fluores-
cence in the absence of irradiation and erythrosine, indicat-
ing a high level of cell viability. However, biofilm samples 
treated with PDT showed an increase in red/yellow fluores-
cence, indicative of dead cells.
Discussion
The present study investigated the bactericidal effect follow-
ing 15 min continuous irradiation and, also, following a frac-
tionated regime of 30 sec light pulses for 5 times separated 
by 1 min dark periods in an attempt to reduce the overall 
PDT treatment time to enhance its clinical usefulness.
Interestingly, the data from the present study showed that 
when the irradiation time was reduced to 2.5 min, which 
was applied in 30 sec light pulses for 5-times separated by 
1min dark periods, the bacterial killing (~ 91%) was effec-
tive and equal to bacterial killing obtained from the 15 min 
continuous irradiation (~ 95%) when 15 min incubation time 
(Arm-1) with erythrosine was used. This may be due to the 
replenishment of oxygen during the dark periods for eryth-
rosine to initiate more photochemical reactions or perhaps 
due to the replenishment/redistribution of the erythrosine 
itself within the biofilm during these dark periods as con-
tinuous irradiation may lower erythrosine levels due to photo 
bleaching (Metcalf et al. 2006; Wood et al. 2006).
These findings agree with Tahmassebi et  al. (2015), 
where their results suggested that the bactericidal effect of 
PDT was photosensitiser and light dose-dependent (Konopka 
and Goslinski 2007; Tahmassebi et al. 2015). However, the 
bacterial reductions observed in the previous studies on S. 
mutans biofilms grown in vitro were higher (3–3.7  log10) 
(Metcalf et al. 2006; Wood et al. 2006) than those found in 
the current study on in vivo-formed biofilms (1–1.36  log10). 
A potential explanation is that in vitro-formed biofilms have 
a limited number of species and have a composition and 
structure that is different to those in in vivo-formed biofilms 
(Watson et al. 2005). As a result, the analysis of undisturbed 
human dental plaque biofilms has been considered as the 
best method for studying the effect of antimicrobial therapies 
on the biofilm structure (Tomás et al. 2010).
Fig. 3  Percentage (%) reduction in viable counts of in vivo formed 
biofilms under different experimental conditions: C1 (No erythros-
ine, no light); C2 (Erythrosine, no light); T1A and T1B (Erythros-
ine, +15 min continuous light); T2A and T2B (Erythrosine, +30 sec 
light pulses for 5 times, separated by dark periods of 1 min) (a, b). 
Data represent median values a (n = 13) b (n = 15). Error bars rep-
resent SD and data followed by different letters differ statistically 
(p < 0.003).
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The effectiveness of antimicrobial PDT has also been 
reported to be dependent on the incubation time of micro-
organisms with photosensitiser (Andrade et al. 2013). Vari-
ous erythrosine-mediated PDT studies have used different 
incubation times prior to irradiation (Metcalf et al. 2006; 
Wood et al. 2006; Chibebe Junior et al. 2010; Rolim et al. 
2012; Pereira et al. 2013; Tahmassebi et al. 2015). However, 
there were no reports in the literature that have compared 
the efficacy of different incubation times on in vivo-formed 
biofilms.
In the present study when 2 min incubation time was 
used, there was less cell death (64%) when applying frac-
tionated light compared to the 15 min continuous light 
(~ 93%). Some erythrosine-based PDT studies have used 
Fig. 4  CLSM images of 14-day 
in vivo formed biofilm samples 
(a–f). a, b Untreated (control) 
biofilm samples. Aggregates of 
bacteria were separated by fluid 
filled voids (black holes-red 
arrow). c, d Biofilm samples 
incubated with erythrosine 
(220 μM) for (c) 15 min or 
(d) 2 min and irradiated for 
continuous 15 min. e, f biofilm 
samples incubated with eryth-
rosine (220 μM) for (e) 15 min 
or (f) 2 min and irradiated for 
fractionated 5 × 30 sec with 
1min dark recovery periods. 
Green fluorescence indicates 
viable bacteria and red/yellow 
fluorescence indicates affected 
bacteria. All images were taken 
with ×63 lens
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5min incubation time (Chibebe Junior et al. 2010; Rolim 
et al. 2012; Pereira et al. 2013), while others have used 
15 min incubation time (Metcalf et al. 2006; Wood et al. 
2006; Tahmassebi et al. 2015) and both times showed sig-
nificant reduction in the bacterial viability. The reasons for 
this difference in the present study are unclear, but may be 
due to the shorter contact time with the photosensitiser that 
could have limited its uptake into the bacterial cells, decreas-
ing (but not negating) the PDT effect.
This outcome partly contradicted the results found in our 
initial PDT study on planktonic cultures of L.casei, where 
different incubation times (2, 5 and 15 min) presented no 
statistical differences on the percentage reduction of bacte-
rial counts (un-published data). This suggests that the effect 
of PDT on dental biofilms is different than on planktonic 
cells. This is likely due to the structural variation in the bio-
films and in bacterial cell membranes or the presence of 
other components, such as extracellular matrix and quorum-
sensing factors in dental biofilms, which render the biofilm 
bacteria more resistant to treatment than planktonic cultures 
(Huang et al. 2012).
CLSM was used to visualise PDT effects on in vivo-
formed biofilms. The present analyses agreed with the pre-
vious studies’ findings on biofilm structure as it showed a 
heterogeneous architecture in terms of types of cells pre-
sent, such as cocci, rods and filaments and also in terms 
of the overall structure where clumps of bacteria were sur-
rounded by extracellular matrix and separated by voids/
channels (black holes) (Wood et al. 2000; Lawrence et al. 
2003; Dige et al. 2007). These voids were thought to be 
filled with biological substances, such as extracellular poly-
meric substances (EPS) and glycoproteins and act as a cir-
culatory system where oxygen and nutrients were available 
in the biofilm (Wood et al. 2000). The few previous studies 
that have evaluated the antibacterial effect of PDT using 
erythrosine by CLSM analysis have used in vitro-formed 
S. mutans biofilms (Wood et al. 2006; Lee et al. 2013). In 
the present investigation, CLSM images showed a marked 
difference in the bacterial viability between the control and 
the PDT-treated samples. In the control samples, almost all 
cells were stained green, indicating viable bacteria. In the 
treated samples, there was uneven spatial distribution of vital 
and dead cells with a higher proportion of dead cells. These 
findings corresponded with the findings of Lee et al. (2013) 
when PDT effects was investigated against in vitro-formed 
biofilms using erythrosine and a dental halogen curing light. 
However, in the present investigation, it was not possible 
to determine which treatment group was superior in terms 
of bacterial killing as no quantitative technique was per-
formed. Nevertheless, there are several explanations for the 
uneven distribution of these vital and dead cells throughout 
the biofilms such as the availability of oxygen for PDT to 
have an effect or having diverse populations of cells that 
have different susceptibilities to PDT. Interestingly, this was 
seen in some plaque samples (shown in Fig. 4c) where the 
rod-shaped bacteria seem to be less susceptible to PDT than 
the coccoid bacteria.
Overall, the bactericidal effects of PDT as seen by CLSM 
has corresponded with the findings of this present study 
when using the microbiological analysis of viable bacte-
rial count, indicating that a combination of microbiological 
techniques and microscopic techniques can help to achieve 
a realistic representation of PDT effect on in vivo formed 
dental plaque biofilms.
Evidently erythrosine-based PDT can cause significant 
reduction of in vivo formed plaque biofilms and might be 
useful for controlling dental plaque related diseases such as 
caries and periodontal disease. Therefore, well conducted 
in situ studies/trials are required to assess the effect of PDT 
clinically if they exist and compare it with the current best 
practice. However, prior to the transition to clinical tri-
als, the mode of delivery of PDT in oral cavity needs to be 
established.
Although the tungsten filament lamp is effective for 
erythrosine-based PDT, the drawback of this light source 
is that it is bulky and, also, generates heat that might cause 
a burning sensation in vivo if not appropriately dissipated. 
Therefore, this source might not be convenient for clinical 
use in patients. One possible alternative would be to use an 
LED light source. These have already been used in dentistry 
as a curing light for restorative materials (Rueggeberg et al. 
2017) and are readily available, small, portable and safe. In 
addition, LEDs do not generate heat like the tungsten fila-
ment lamp. Several antimicrobial erythrosine-based PDT 
studies have used LEDs and showed successful outcomes 
(Chibebe Junior et al. 2010; Rolim et al. 2012; Pereira et al. 
2013).
In addition, erythrosine has already been used in dentistry 
to stain and visualise dental plaque in the form of disclosing 
solution or tablets to facilitate oral hygiene instructions (Wood 
et al. 2006). In plaque disclosing solutions, it is used at concen-
trations of 9–25 mM (0.72–2% weight/volume) (Marsh et al. 
1989), which is much higher than that used in several PDT 
studies (Tahmassebi et al. 2015; Metcalf et al. 2006; Wood 
et al. 2006) and, also, in this current study, which was 220 μM. 
Erythrosine’s antimicrobial property against Gram-positive 
and Gram-negative oral bacteria (Marsh et al. 1989; Baab et al. 
1983; Caldwell and Hunt 1969; Begue et al. 1966) as well as 
its light-absorbing property and the ability to initiate photo-
chemical reactions (Wood et al. 2006) are well documented 
in the literature. Therefore, erythrosine presents advantages 
over other dyes for the use in PDT, because it is already been 
approved for the use in dentistry by the US Food and Drug 
Administration (FDA) to visualise dental plaque. In addition, 
it does not show direct toxicity to the host tissue (Carrera et al. 
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2016; Ganesan et al. 2011; Allaker and Douglas 2009; Wood 
et al. 2006; Arnim 1963).
Therefore, the combination of an LED light source and 
erythrosine varnish should be considered and studied for PDT 
clinical trials in the near future. As both of them are commonly 
used in dental clinics, PDT could be made available without 
significant additional cost. However, its cost effectiveness 
should be measured against the current best practice.
This technique can be used at home as an adjunct to 
mechanical removal or by itself where brushing is not tol-
erated, such as in cases with mucositis, to decrease the oral 
bacterial load; hence, preventing/controlling dental caries and 
periodontal disease. It can be delivered in a way similar to the 
bleaching trays with attachable LED light unit and integrated 
timer. The erythrosine can be supplied as a varnish or in inject-
able syringes for ease of topical application. However, more 
research is needed to assess its effectiveness compared with 
the current best practice.
Conclusions
This study has shown that improving the clinical usefulness 
of photodynamic therapy is possible by reducing the incuba-
tion time with erythrosine from 15 min to 2 min with 15 min 
irradiation time. Further research is; however, needed to inves-
tigate a more clinically acceptable irradiation time, as this is 
particularly necessary for special needs patients and younger 
children with short attention span.
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